GameStop surges 27% to lead meme stock rally in otherwise boring market


CNBC 24 August, 2021 - 03:18pm 62 views

It isn’t quite dominating the headlines to the extent it was a few weeks back, but the battle between Scarlett Johansson and Disney over her Black Widow lawsuit is still bubbling away in the background. It’s devolved into schoolyard name-calling in some respects, with the Mouse House’s representatives at various points blasting the actress for being greedy and calling her legal action a PR stunt.

Nobody’s obligated to publicly pick sides in situations like these, but Dune director Denis Villenueve fully backed the longtime Natasha Romanoff, which isn’t much of a surprise when he’s been highly critical of Warner Bros. sending the entire slate of 2021 movies to HBO Max the same day they hit theaters.

Elizabeth Olsen is the latest high profile name to offer her support to Johansson, answering with a simple “good for her” when asked for her thoughts on the Black Widow debacle. As you can see from the reactions below, though, some Marvel Cinematic Universe fans are worried that there could end up being repercussions for the star.

Since Elizabeth Olsen is now supporting Scarlett Johansson in her Disney suit, me thinks Wanda will be either killed off on Doctor Strange 2 or have some body exchange spell. If the latter, cast Alicia Vikander.

Disney's about to blacklist Elizabeth Olsen now

Elizabeth Olsen supports Scarlett Johansson in suing Disney. This is me if Wanda dies in Doctor Strange in the Multiverse of Madness

Elizabeth Olsen is backing up Scarlet Johansson on her lawsuit and this is what plays in my mind. #disney #ScarlettJohansson #ElizabethOlsen

At the end of the day, Olsen is under contract with Marvel Studios and not Disney, similar to Johansson, and the latter has no issues with Kevin Feige or his team when it was the outfit’s parent company that made the Premier Access call. Besides, Scarlet Witch is established as the franchise’s most powerful character and Doctor Strange in the Multiverse of Madness is just seven months away from release, so it’s probably safe to assume the Emmy nominated WandaVision lead will be just fine.

Source: Epicstream

Read full article at CNBC

Why Meme Stocks AMC, GameStop, and Tonix Rocketed Higher Today | The Motley Fool

The Motley Fool 23 August, 2021 - 06:27pm

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

Meme stock investors had a satisfying Monday, with three of the top names in that rather loosely defined group -- AMC Entertainment (NYSE:AMC), GameStop (NYSE:GME), and Tonix Pharmaceuticals (NASDAQ:TNXP) -- all convincingly beating the S&P 500 index's gain.

The trio closed the day higher by, respectively, 6.9%, 3.5%, and 4.2%.

Stock bulls were running rampant on Monday, largely because of the very happy news that the coronavirus vaccine developed by Pfizer and BioNTech received full FDA approval.

Previously, the jab -- now brand-named Comirnaty on our shores -- had only been granted Emergency Use Authorization, an important distinction.

The impact of the vaccine's approval on Tonix Pharmaceuticals is clear. The biotech company is developing its own coronavirus vaccine, and the FDA's nod on Pfizer's proves the regulator is eager to get jabs through the pipeline and into human arms.

It also affects AMC and GameStop, but in a less direct way: Some holdouts might get their shots now that there's a fully FDA-approved vaccine. That's potentially good news for venues potentially packed with humanity, like AMC's movie theaters.

The reasoning is similar for GameStop. Outside of console or hot game launch days, the company's many brick-and-mortar locations aren't usually packed with people, but with greater inoculation rates and a lower risk of infection, more people are likely to visit the stores.

Discounted offers are only available to new members. Stock Advisor will renew at the then current list price. Stock Advisor list price is $199 per year.

Stock Advisor launched in February of 2002. Returns as of 08/24/2021.

Making the world smarter, happier, and richer.

Market data powered by Xignite.

Business Stories